Overview A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846 Status: Recruiting Trial end date: 2024-12-31 Target enrollment: Participant gender: Summary A Clinical trial to compare and evaluate evaluate the pharmacokinetics and safety of CKD-846 Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical